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synthesized and cloned in the composition of plasmid pcDNA3.1
that is eukaryotic expression vector. Accuracy of gene insertion
encoding polyepitopeimmunogen was verified using restriction
analysis. Obtained target plasmid pBC-A*0201 – candidate DNA-
vaccine was used for evaluation of gene expression in transfected
eukaryotic cells 293T and dendritic cells by means of flow cytoflu-
orometry and immunohistochemistry using MAT to p24 epitope-
marker inserted into the structure of target plasmid. Dendritic
cells were obtained from peripheral blood precursors by 2-h plas-
tic adhesion. The nonadherent cells were removed 2 h later and
the adherent monolayer was cultivated in the medium containing
growth factors (GM-CSF and IL-4) according to (Naik, 2010; Ganul
and Khranovskaya, 2012). Transfection of immature DCs (iDC)
was performed by using the reagents purchased from Promokine.
Further cultivation of iDCs was carried out in the medium con-
taining TNF- a to obtain fully mature DCs (mDC). Analysis of
mDCsurface markers expression was made using MAO (HLA-
DR, CD83, CD86) and flow cytofluorometer (BD FACSCalibur).
Results: Plasmid pBC-A*0201 encoding epitopes of breast can-
cer antigens was constructed and produced in preparative
amount. Using the method of intracellular staining of product
of expression by specific MAO 29F2 to epitope p24, we showed
expression of gene BC-A*0201 in eukaryotic cells 293T and
dendritic cells transfected by plasmid pBC-A*0201. Maturity of
dendritic cells was also proved.
Conclusion: Thus, obtained candidate DNA-vaccine encoding
target polyepitopeimmunogen provides synthesis of relevant
protein in the eukaryotic cells culture. In future, we plan to study
biological activity of DNA-vaccine to evaluate level of induction of
cytotoxic response against SKBR3 breast cancer cells.
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Differently sized microparticles, including exosomes (30–
100 nm), prostasomes (50–500 nm), oncosomes (50–500 nm) and
other microparticles (100–1000 nm) were found in blood and
urine. Exosomes from prostate cancer (PCa) patients can poten-
tially contain cancer-specific nucleic acids, and thus can repre-
sent a valuable source of diagnostic material. In this study, we
have investigated microvesicles and miRNA from urine of healthy
donors and PCa patients. To isolate miRNAs from urine and
microparticles, novel methods for miRNA isolation were elabo-
rated (Rus. patent application No 2014137763, priority date
17.09.2014). The study population included 14 patients with PCa
(63–82 years, T2-3NxMx1) and control group of 20 healthy
volunteers with no previous history of prostate disease
(48–73 years). Urine was clarified by two serial centrifugations at
400g, 20 C, 20 min and at 17000g, 20 C, 20 min. Microparticles
were precipitated from the resulting supernatant by high-speed
centrifugation at 100000g, 18 C, 90 min, the pellet was resus-
pended and pelleted by centrifugation under the same condi-
tions. To isolate exosomes, total microparticles were filtered
through 0.1 lm pore filters and reprecipitated. The resulting pel-
lets were resuspended and exosome samples were investigated
by transmission electron microscopy (TEM). MiRNAs were iso-
lated by one-step single-phase protocol and purified using ‘‘BioSil-
ica” spin- columns (Zaporozhchenko et al., Anal. Biochem,
upcoming, doi: 10.1016/j.ab.2015.03.028) and by recently devel-
oped method based on precipitation of excess biopolymers,
allowing to isolate miRNAs with better efficiency than commer-
cially available kits. The size and quantity assessment of extracel-
lular RNAwere performed using capillary electrophoresis system
on Agilent 2100 Bioanalyzer. Concentrations of miRNAs (miR19b,
miR25, miR205, miR125b, miR126) were measured by qRT-PCR and
normalized to miR-16 using dCq method.
TEM demonstrated the presence of 20–300 nm microparticles
in urine of healthy donors and PCa patients. Approximately
50–70% of all urine microparticles are represented by 30–100 nm
exosomes and residual 30–50% by particles larger than 100 nm.
(The pool of urine microvesicles consists of 50–70% exosomes
and 30–50% particles larger than 100 nm.).
The major part of extracellular RNA found both in exosomes
and total microparticles fraction of healthy donors and patients
with PCa, is 25–200 nt long and can include tRNA (73–93 n.), 5.8
rRNA (150 n.), snoRNK (10–20 n.), snRNA (60–300 n.) piRNAs
(29–30 n.), miRNAs (20–25 n.), siRNA (21–25 n.). Concentration of
extracellular urine RNA in exosomes and total microparticles of
healthy donors and patients with PCa amounts to100 pg/ml of
urine on average.Receiver Operating Characteristic (ROC) curve
analysis of all miRNAs in samples isolated from total urine did
not demonstrate any diagnostic significance. In contrast, in train-
ing cohort concentration of miR-19b in exosomes and total
microparticles fraction provide 95%/75% and 93%/100% sensitivity
and specificity, respectively.
Thus, microparticles, isolated from urine of PCa patients
represent a valuable source of diagnostically significant miRNAs.
To investigate miR-19b, a large testing cohort is required. Search
for other potential miRNA-markers by microarray profiling of
cell-free miRNA isolated from urine of PCa patients is also
required to reveal a sold set of markers for confident PCa
diagnostics.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.014
A111
Expressing FOXP3 in determining the biological characteristics of
endometrial adenocarcinomas
L. Buchynska*, N. Iurchenko, N. Verko, N. Glushchenko. RE
Kavetsky Institute of Experimental Pathology, Oncology and
Radiobiology, National Academy of Sciences of Ukraine, Kiev, Ukraine
⇑
Corresponding author.
8 EJC SUPPLEMENTS 13 (2015) 1–75
Background: According to the ‘‘immune-editing” theory,
immunocompetent cells being important component of the
tumor microenvironment can both show antitumor activity and
contribute to the tumor progression. Tumor pathophysiological
features affect the structural and functional changes of certain
components of tumor microenvironment, in particular, increase
the number of T-lymphocytes with regulatory activity (Treg).
FOXP3, transcription factor, acts as master regulator for
suppressive function of Treg. Recent studies have shown FOXP3
is expressed both in immunocompetent cells and tumor cells;
however, the function of this gene in malignant tumors of
different genesis is ambiguous (GirdhariLal, et al., 2014). The
aim of the study was quantitative assessment of subpopulations
CD4+, CD8+, FOXP3+-lymphocytes associated with the tumor,
FOXP3+-tumor cells and comparison of these parameters with
the clinical and morphological characteristics of endometrial
cancer (EC).
Materials and methods: A total of 40 EC patients who did not
receive special treatment before surgery with the mean age
56.9 ± 2.8 years were included in the study. Morphological and
immunohistochemical methods were used in the study (primary
monoclonal antibodies: CD4 – clone 4B12, ‘‘Millipore”, USA,
CD8 – clone RIV – 11, ‘‘Millipore”, USA, FOXP3 – clone 5H5L12,
‘‘Invitrogen”, USA, Ki-67 - clone MIB1, ‘‘DakoCytomation”,
Denmark) and Real-Time PCR was also used to determine the
DNA methylation status of FOXP3 gene mathematical statistics.
Results: The dependence of the number of intratumoral CD4+-,
CD8+- lymphocytes and FOXP3-lymphocytes on such biological
characteristics as the degree of differentiation, growth rate and
depth of invasion into the myometrium was established. In
endometrial adenocarcinomas, low grade content of FOXP3+ lym-
phocytes increased (27.8 ± 2.6%), number of intratumoral CD4+
(15,3 ± 0,2%), CD8+-lymphocytes (29.6 ± 0.3%) and FOXP3+-tumor
cells (15,5 ± 3,3%) decreased in contrast to the same parameters
in high grade tumors: FOXP3+-lymphocytes (17.4 ± 3.0%),
CD4+ (52.0 ± 2.7%), CD8+ (46.4 ± 5.6%), FOXP3+-tumor cells
(27.8 ± 2.6%), p < 0.05. DNA analysis of endometrial tumor
showed that FOXP3 gene promoter was methylated in 71% of
cases. The number of cases with positive methylation status
was increasing with lower differentiation grade, that was associ-
ated with the low number of FOXP3+-tumor cells. Statistically sig-
nificant correlation (p < 0.05) (Spearman rank correlation) was
observed between the deep invasion of tumor in myometrium
and the number of FOXP3+-tumor cells (R = 0.63), number of
FOXP3+- and CD4+-lymphocytes (R = 0.68 andR = 0.55, respec-
tively) as well as the level of tumor proliferative activity
(R = 0.74).
Conclusion: Quantitative changes of some components of the
tumor microenvironment such as CD4+-, CD8+-, FOXP3+-
lymphocytes and content of FOXP3+-tumor cells correlate with
the biological characteristics of EC and apparently have a
significant role in the progression of this cancer.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.015
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Background: The aim of the study was to identify the factors
that determine outcome and overall survival of HNC patients of
Tomsk region.
Materials and methods: Clinical data, morphological charac-
teristics of tumors and outcomes were obtained for 91 patients.
Data about lifestyle, food preferences, smoking history were
obtained from the questionnaire (n = 35). All clinical samples
were tested by AmpliSens HPV diagnostic kits (Russia) to deter-
mine prevalence of 12 high risk HPV types. Statistical analysis
was performed using Kaplan–Meier method, Cox regression,
Gehan test, Fisher test, Mann–Whitney and Kruskal–Wallis tests.
Results: Gender, age, smoking status, alcohol consumption,
distance from harmful factors, professional hazards and duration
of its exposure as well as tumor criteria such as T, N, G, the pres-
ence of keratinization, invasion into the underlying tissues, HPV-
infection, chemotherapy and/or radiation therapy and response
to the treatment were assessed for HNC patients. It was shown
that the two-year survival rate was about 70%, and the five-year
survival rate was about 32%. There was strong correlation
between decreased overall survival and increased alcohol con-
sumption (p = 0.03) as well as regional lymph nodes status
(p = 0.01). Patients with early tumor stages and N0 lymph node
status as well as patients receiving chemotherapy and/or radio-
therapy showed trend towards to better survival (p = 0.09,
p = 0.1, p = 0.09, respectively). Overall survival of patients with
lymph node metastasis was higher in case of early tumor stages
(p = 0.08) and in patients who had no alcohol consumption history
(p = 0.06). Cox regression analysis was used to obtain the model
describing overall survival of patients. The model with the high-
est level of significance includes 3 factors-nodal metastases, the
presence of keratinization and radiotherapy. It was shown that
the risk of death was 4.2 and 2.6-fold higher in case of lymph
node metastases and keratinized cancer, and 2.7-fold lower in
case of radiotherapy. It was also shown that metastasis occurred
more frequently in cases with invasion into the underlying tissue
of a primary tumor (p = 0.04) and in cases with a low tissue grade
(p = 0.02). Association of alcohol consumption with questionnaire
data was studied. It was shown that men’s preferably smokers
consume alcohol more often than other patients (p = 0.006,
p = 0.02, respectively). Our data showed that HPV prevalence
was higher in smokers (p = 0.04), and in patients with early tumor
stages (p = 0.07). Furthermore, response to radiotherapy was
better in HPV-positive patients compared to HPV-negative cases
(p = 0.09). Better response to radiotherapy showed the group of
patients who received dose higher than 45 Gy (p = 0.03) and who
had no lymph node metastases(p = 0.05).
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